Target intelligence / Profile preview

Ultraviolet A Radiation (UVA)

Target: UVA
Molecular classification: Electromagnetic radiation

Overview

Ultraviolet A (UVA) radiation is a type of electromagnetic radiation with a wavelength of 320–400 nm. It penetrates deeply into the skin, causing indirect DNA damage through the generation of reactive oxygen species (ROS), leading to photoaging, increased skin cancer risk, eye damage, and immune suppression. It is not considered a therapeutic target.

Other names: Long-wave ultraviolet radiationUVA light

Biological functions

Melanin oxidationReactive oxygen species (ROS) generationDNA damage (indirect)Photoaging inductionImmune suppression

Disease associations

Skin cancer (carcinogenesis)Premature skin aging (photoaging)CataractsEye damageImmune suppression related malignancies

Safety considerations

Skin cancer riskPhotoagingEye damageImmune suppression

Beyond the preview

Go deeper on Ultraviolet A Radiation (UVA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ultraviolet A Radiation (UVA).

Explore the full profile